Mouse Anti-Human Factor I Monoclonal Antibody (CTJS-840) [Biotin](Cat#: CTA-636)

This product is a conjugated anti-Human Complement Factor I Monoclonal antibody (CTJS-840) generated from the Mouse. The antibody can be used for ELISA.

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number

Summary Related Products & Services

Specifications
Clonality Monoclonal
Clone CTJS-840
Host Animal Mouse
Isotype IgG1
Immunogen Human complement Factor I
Species Reactivity Human
Applications ELISA
Application Notes The optimal working dilutions should be determined by the end user.
Specificity This antibody reacts with Human Complement Factor I.
Purity ≥95% as determined by SDS-PAGE
Conjugation Biotin
Format Liquid
Size 100 µg
Storage Store in dark at 4°C. Do Not Freeze.
Type Primary Antibody
Target
Target Name Factor I
Alternative Names Complement Factor I; Konglutinogen-Activating Factor; C3B/C4B Inactivator; C3b-Inactivator; C3b-INA; Complement Control Protein Factor I; Complement Factor I Heavy Chain; Light Chain Of Factor I; Complement Component I; I Factor (Complement); CFI
Gene ID 3426
UniProt ID P05156
Information
Introduction Trypsin-like serine protease that plays an essential role in regulating the immune response by controlling all complement pathways. Inhibits these pathways by cleaving three peptide bonds in the alpha-chain of C3b and two bonds in the alpha-chain of C4b thereby inactivating these proteins. Essential cofactors for these reactions include factor H and C4BP in the fluid phase and membrane cofactor protein/CD46 and CR1 on cell surfaces. The presence of these cofactors on healthy cells allows degradation of deposited C3b by CFI in order to prevent undesired complement activation, while in apoptotic cells or microbes, the absence of such cofactors leads to C3b-mediated complement activation and subsequent opsonization.
For Research Use Only. Not for Diagnostic or Therapeutic Applications.
Online Inquiry